-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
TriSalus Life Sciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2020 to Q4 2024.
- TriSalus Life Sciences, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$7.58M, a 47% increase year-over-year.
- TriSalus Life Sciences, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$36.2M, a 33.6% increase year-over-year.
- TriSalus Life Sciences, Inc. annual Operating Income (Loss) for 2024 was -$36.2M, a 33.6% increase from 2023.
- TriSalus Life Sciences, Inc. annual Operating Income (Loss) for 2023 was -$54.5M, a 49.5% decline from 2022.
- TriSalus Life Sciences, Inc. annual Operating Income (Loss) for 2022 was -$36.4M, a 1098% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)